Hi SlingWing, saw your remarks about HALB's partners on the Intro page of this message board. Think we will get a lot of updates of the company that will prove your wrong. You say: "Halberd holds no patents as they are held by Marv Enterprises".
But you know all relevant patents and provisional patents were licensed to HAL. I gave you the link to the filed (by BIEI) Form 8K. All MARV's patents were licensed to HALB on 05/12/2020:
Exhibit 10.2
INTELLECTUAL PROPERTY AGREEMENT
This Intellectual Property Agreement (this “Agreement”) is entered into on May 12, 2020 (“Effective Date”), concerning the pursuits set forth herein for the collective development, implementation and commercialization of a potential treatment for the COVID-19 virus and its effects on the human body (collectively referred to herein as the “Joint Venture”) by and between:
Marv Enterprises, LLC, a Limited Liability Company organized under the laws of the Commonwealth of Pennsylvania (“Marv”),
Premier Biomedical, Inc. (OTC Pink: BIEI), a Nevada corporation (“Premier”),
Technology Health, Inc. (OTC Pink: HALB), a Colorado corporation f/k/a Halberd Corporation (“THI”),
Each shall be referred to as a “Party” and collectively as the “Parties.”
RECITALS:
WHEREAS, Marv is a single member LLC with Dr. Mitchell Felder as the sole member.
WHEREAS, Premier is publicly traded on the Pink Sheets, trading symbol BIEI.
WHEREAS, THI is publicly traded on the Pink Sheets, trading symbol HALB.
WHEREAS, Marv is owner of U.S. Patent 9,216,386 and U.S. Patent 8,758,287 collectively referred to as the “Issued Patents”.
WHEREAS, Premier has an Exclusive License to the Issued Patents via an Agreement executed by Marv and Premier on May 12, 2010 (“2010 Agreement”).
WHEREAS, Marv has subsequently filed numerous patent applications on subject matter related to the Issued Patents which are listed in Appendix A.
WHEREAS, Marv and Premier expanded Premier’s Exclusive License to include all the Applications listed in Appendix A via a Third Addendum to the 2010 Agreement executed by Marv and Premier on the Effective Date (“2020 Agreement”).
WHEREAS, Marv has filed US provisional patent applications specifically related to methods of treatment for Covid-19 as starred in Appendix A (Covid-19 Applications) to which Premier has an exclusive license via the 2020 Agreement.
WHEREAS, this Agreement contemplates the development of a methodology for the extracorporeal treatment of a patient’s body fluid to treat Covid-19 (Field of Covid-19 Treatment).
WHEREAS, the Parties are desirous of collaborating for the creation and distribution of products designed in the Field of Covid-19 Treatment (Covid-19 Licensed Products)
WHEREAS, THI is desirous of exclusively licensing the Applications listed in Appendix A;
WHEREAS, Premier is willing to assign its rights in the 2010 Agreement/2020 Agreement;
WHEREAS, Marv in this Agreement gives its written consent for Premier to assign its rights in the 2010 Agreement/2020 Agreement to THI;
Etc etc.
Everything I said on the HALB intro page is true and press releases and filings that were announced earlier will confirm that. It will be about VA Hospitals, University of El Paso, Datatecnics and funding. Good luck
News 
Market Data 
Discover 
